Phosphodiesterase type 5 inhibitors improve male lower urinary tract symptoms

Eur Urol. 2008 Jun;53(6):1121-3; discussion 1123-4. doi: 10.1016/j.eururo.2008.02.026. Epub 2008 Mar 5.

Author

François Giuliano

PMID: 18329786
DOI: 10.1016/j.eururo.2008.02.026

No abstract available

Publication types

Comment
Editorial

MeSH terms

Humans
Male
Phosphodiesterase 5 Inhibitors*
Phosphodiesterase Inhibitors / therapeutic use*
Prostatism / drug therapy*

Substances

Phosphodiesterase 5 Inhibitors
Phosphodiesterase Inhibitors